2016 American Transplant Congress

Monday, June 13, 2016

3:18pm-3:30pm

Tolerance Induction with Donor Bone Marrow Transplantation in Kidney Transplantation.

H. Park,¹ N. Lee,¹ S. Lee,¹ G. Choi,¹ C. Kwon,¹ S. Kim,¹ J.-W. Joh,¹ M. Kim,² Y. Kwon,² S.-K. Lee.¹

Concurrent Session: Clinical Science: Tolerance: Clinical Studies  •  Room 304

3:18pm-3:30pm

Tracking Endogenous B Cells Recognizing Allogeneic MHC Class II in Mice.

J. Yang,^1,2 J. Chen,¹ A. Akl,¹ R. Sciammas,³ A. Chong.¹

Concurrent Session: B Cells in Rejection and Tolerance: Animal Models  •  Room 310

3:18pm-3:30pm

Utilization and Post-Transplant Outcomes Associated with Hepatitis C+ Donor Kidneys in the Advent of Direct-Acting Antivirals.

M. Bowring, L. Kucirka, A. Massie, X. Luo, M. Sulkowski, D. Segev, C. Durand.

Concurrent Session: Kidney Transplantation: Allocation, Discard, and HCV  •  Veterans Auditorium

3:18pm-3:30pm

Viral Gastroenteritis in Adult and Pediatric Solid Organ Transplant (SOT) Patients.

C. Hernández Garcia,¹ B. Lee,¹ X. Pang,² H. Yuan Zhou,¹ J. Preikisatis.¹

Concurrent Session: Various Viruses, Vaccines, and SOT  •  Room 306

3:30pm-3:42pm

Acute Kidney Injury (AKI) Associated with Chronic Kidney Disease (CKD) in Paediatric Non-Kidney Transplant Recipients.

C. Williams,^1,2 K. Borges,² T. Banh,² J. Vasilevska-Ristovska,² R. Chanchlani,^1,2 V. Ng,^1,2 A. Dipchand,^1,2 M. Solomon,^1,2 D. Hebert,^1,2 S. Kim,^1,3 B. Astor,⁴ R. Parekh.^1,2,3

Concurrent Session: Kidney: Pediatrics  •  Room 311

3:30pm-3:42pm

Belatacept Does Not Inhibit Plasmablast Formation Supported by Follicular T Helper Cells, but Favors the Development of Transitional Regulatory B Cells in Kidney Transplant Patients.

G. de Graav, D. Hesselink, M. Dieterich, R. Kraaijeveld, W. Weimar, C. Baan.

Concurrent Session: B Cells in Rejection and Tolerance: Animal Models  •  Room 310

3:30pm-3:42pm

Clonal Expansion of Donor-Specific Tregs Following Combined Kidney and Bone Marrow Transplantation.

T. Savage,¹ S. Dewolf,¹ A. Obradovic,¹ S. Lau,¹ J. Zuber,¹ L. Turka,^2,3 Y. Shen,¹ M. Sykes.¹

Concurrent Session: Clinical Science: Tolerance: Clinical Studies  •  Room 304

3:30pm-3:42pm

Decline of HCV RNA and Core Antigen: Predictors of Achieving SVR in Transplant Recipients Undergoing DAA-Therapy.

S. Pischke,³ V. Proske,¹ S. Polywka,⁴ M. Lütgehetmann,⁴ M. Lang,¹ S. Stauga,¹ L. Fischer,¹ A. Lohse,³ B. Nashan,² M. Sterneck.¹

Concurrent Session: Viral Hepatitis  •  Ballroom A

3:30pm-3:42pm

Donor-Specific Antibody Is a Major Independent Predictor of Accelerated Heart Allograft Vasculopathy (CAV).

M. Bories,¹ S. Varnous,² C. Lefaucheur,³ P. Rouvier,² R. Guillemain,¹ P. Bruneval,¹ J. Duong Van Huyen,⁴ A. Loupy.⁴

Concurrent Session: Molecular and Bio-Markers in Hearts and VADs - A New Hope  •  Room 102

3:30pm-3:42pm

Effect of Complement Inhibition Therapy (Eculizumab) in Patients with C1q-Binding Donor-Specific Anti-HLA Antibodies: A Molecular Appraisal.

C. Lefaucheur,¹ L. Hidalgo,² J. Reeve,² D. Viglietti,¹ C. Gosset,¹ O. Aubert,³ C. Ulloa,³ C. Legendre,³ D. Glotz,¹ P. Halloran,² A. Loupy.³

Concurrent Session: Identifying Antibodies - Tools of the Trade  •  Ballroom B